Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Researchers Discover the Genetic Signature of Highly Aggressive Small Lung Tumors

Published: Thursday, October 03, 2013
Last Updated: Thursday, October 03, 2013
Bookmark and Share
A study conducted by the IDIBELL allows to identify this type of cancer at an early stage and adapt the treatment.

Lung cancer is currently the most lethal in the world. The main cause of these tumors is the tobacco and it is usually diagnosed in advanced stages when there are already few treatment options. There is a subgroup of tumors of the lung that thanks to diagnostic advances can be detected in early stages and in which the surgery can be more healing. These are the so-called small lung tumors.

However, one third of these tumours are highly aggressive and highly prone to generate metastases.

On September 30 the official journal of the American Society of medical oncology, the Journal of Clinical Oncology, publishes an article headed by Manel Esteller, Director of the Programme in Epigenetics and Biology of Cancer of the Biomedical  Research Institute of Bellvitge (IDIBELL), ICREA researcher and Professor of genetics of the University of Barcelona, that allows to identify these tiny but highly malignant lung tumours.

"The study is an international project funded by the European Union where we analyzed lung cancer in stage I, those tumours where surgery may be curative. We have found that one of every three small tumours will reappear and be associated with the death of the patient. But the most important thing is that we can already begin to identify which cancers will behave that way so aggressivly" explained Manel Esteller, director of the study.

"By analyzing DNA of these tumours we found that alterations in their genetic programme, the so-called epigenetic lesions, associated with their greater ease to grow and expand to the rest of the body. Specifically, they present changes in genes that turn them into undifferentiated tumours (homeobox genes) with a softer appearance (mesenchymal genes)

The finding represents not only the discovery of prognostic markers of the disease indicating how fast the tumour will progress, but also it may be useful for treatment. "If we know the small tumour is going to be very aggressive, better that we are not content with the simple surgical eradication of the same one and begin studying if we must add chemotherapy to treat these tumors of high risk” it concludes Manel Esteller.

In Europe are diagnosed each year more than 150,000 cases of lung cancer, 90% of them due to tobacco. Only between 10 and 15% survive five years after diagnosis.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Method Developed to Diagnose Hereditary Breast and Ovarian Cancer
Massive sequencing algorithm and bioinformatic analysis to detect very efficiently genetic mutations linked to the disease.
Wednesday, January 16, 2013
IDIBELL and ICFO Researchers Develop Technology that Predicts Metastasis in Breast Cancer
Raman is a promising microspectroscopy technique for identifying metastatic phenotype of breast cancer cells from their lipid profile.
Monday, October 22, 2012
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos